Leigha Senter

发表

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

A genome-wide association study yields five novel thyroid cancer risk loci

Sandya Liyanarachchi, Kari Stefansson, Gudmar Thorleifsson, 2017, Nature Communications.

No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome

Ignacio Blanco, Kristiina Aittomäki, Rainer Lehtonen, 2010, Familial Cancer.

Identification of Individuals at Risk for Lynch Syndrome Using Targeted Evaluations and Genetic Testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer Joint Practice Guideline

Kory Jasperson, Paul E. Wise, Henry T. Lynch, 2012, Journal of Genetic Counseling.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

Gord Glendon, Lesley McGuffog, Daniel Barrowdale, 2012 .

Salivary gland cancer in BRCA-positive families: a retrospective review.

Amanda E Toland, R. Nagy, A. Toland, 2014, JAMA otolaryngology-- head & neck surgery.

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting

Muin J. Khoury, Kory Jasperson, Maren T. Scheuner, 2011, Genetics in Medicine.

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Päivi Heikkilä, Mads Thomassen, Stephen Fox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.